Rapidly acting antitumoral antiangiogenic therapies

被引:15
|
作者
d'Onofrio, Alberto [1 ]
机构
[1] European Inst Oncol, Div Epidemiol & Biostat, I-120141 Milan, Italy
来源
PHYSICAL REVIEW E | 2007年 / 76卷 / 03期
关键词
D O I
10.1103/PhysRevE.76.031920
中图分类号
O35 [流体力学]; O53 [等离子体物理学];
学科分类号
070204 ; 080103 ; 080704 ;
摘要
We deal with a biophysical description of antitumor antiangiogenic therapies. In particular, by means of some simple models, we study the possible effects of the delay between the drug consumption by endothelial cells and their death on the outcome of the therapy. We have found that this time lag implies an increase in the minimal dose guaranteeing tumor eradication and, if the delay is greater than a meaningful threshold, it may preclude the total regression. These results might be of interest in better understanding the causes underlying the contradictory literature on the clinical trials of antiangiogenic therapies.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model
    Soltau, Jens
    Zirrgiebel, Ute
    Esser, Norbert
    Schaechtele, Christoph
    Totzke, Frank
    Unger, Clemens
    Merfort, Irmgard
    Drevs, Joachim
    ANTICANCER RESEARCH, 2008, 28 (2A) : 933 - 941
  • [22] Antiangiogenic therapies for malignant pleural mesothelioma
    Yano, Seiji
    Li, Qi
    Wang, Wei
    Yamada, Tadaaki
    Takeuchi, Shinji
    Nakataki, Emiko
    Ogino, Hirokazu
    Goto, Hisatsugu
    Nishioka, Yasuhiko
    Sone, Saburo
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 740 - 748
  • [23] Novel antiangiogenic therapies in ovarian cancer
    Stuckey, Ashley
    Dizon, Don S.
    WOMENS HEALTH, 2012, 8 (04) : 447 - 453
  • [24] Antiangiogenic Therapies: Going beyond Their Limits
    Moserle, Lidia
    Jimenez-Valerio, Gabriela
    Casanovas, Oriol
    CANCER DISCOVERY, 2014, 4 (01) : 31 - 41
  • [25] Development of antiangiogenic therapies for ovarian cancer
    Markowska, A.
    Lubin, J.
    Madry, R.
    Markowska, J.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (04) : 303 - 306
  • [26] Antiangiogenic Resistance: Novel Angiogenesis Axes Uncovered by Antiangiogenic Therapies Research
    Jimenez-Valerio, Gabriela
    Casanovas, Oriol
    CURRENT DRUG TARGETS, 2016, 17 (15) : 1728 - 1734
  • [27] Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum
    Dias, PF
    Siqueira, JM
    Vendruscolo, LF
    Neiva, TD
    Gagliardi, AR
    Maraschin, M
    Ribeiro-do-Valle, RM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (04) : 436 - 446
  • [28] Antiangiogenic therapies in the management of breast cancer
    Marme, F.
    ONKOLOGIE, 2010, 33 : 79 - 79
  • [29] Renal cell carcinoma and antiangiogenic therapies
    Pouessel, Damien
    Culine, Stephane
    Verhoest, Gregory
    Patard, Jean-Jacques
    PRESSE MEDICALE, 2008, 37 (04): : 628 - 633
  • [30] Antiangiogenic Therapies for Advanced Hepatocellular Carcinoma
    Sampat, Keeran R.
    O'Neil, Bert
    ONCOLOGIST, 2013, 18 (04): : 430 - 438